The STREAM2 trial: How should we treat multi-drug resistant tuberculosis? - a podcast by MRC Clinical Trials Unit at UCL

For World TB Day, this episode explores the global burden of tuberculosis (TB) and how growing antibiotic resistance can complicate treatment options. Andrew Nunn, a Professor of Epidemiology, discusses his work on the STREAM2 trial, which investigated how treatment for multi-drug resistant TB could be shortened and made more acceptable for patients.

Further information is available on the STREAM Stage 2 study page at www.mrcctu.ac.uk and results from STREAM2 are published open access in The Lancet.For questions or feedback on the series, message us at mrcctu.engage@ucl.ac.uk

For more information and to access the transcript: http://bit.ly/3TDnz24As a listener, your opinion is very valuable to us. Please help us to improve the podcast in future by filling in this short survey: https://forms.office.com/e/PjfjQ5Mn6g

Further episodes of MRC CTU Podcasts

Further podcasts by MRC Clinical Trials Unit at UCL

Website of MRC Clinical Trials Unit at UCL